Association between outdoor particulate air pollution and the risk of osteoporosis: a systematic review and meta-analysis JJ. LiuSB. FuXL. Tang Review 06 May 2021 Pages: 1911 - 1919
How can the orthopedic surgeon ensure optimal vitamin D status in patients operated for an osteoporotic fracture? T. ChevalleyM.L. BrandiR. Rizzoli Review Open access 20 May 2021 Pages: 1921 - 1935
Burden of disease and clinical targets in adult patients with X-linked hypophosphatemia. A comprehensive review S. GianniniM.L. BianchiM.L. Brandi Review Open access 19 May 2021 Pages: 1937 - 1949
An assessment of intervention thresholds for very high fracture risk applied to the NOGG guidelines J. A. KanisH. JohanssonE. V. McCloskey Original Article 04 April 2021 Pages: 1951 - 1960
The treatment gap after major osteoporotic fractures in Denmark 2005-2014: a combined analysis including both prescription-based and hospital-administered anti-osteoporosis medications M. K. SkjødtM. T. ErnstB. Abrahamsen Original Article Open access 15 March 2021 Pages: 1961 - 1971
Impact of population-based or targeted BMD interventions on fracture incidence N. C. HarveyJ. A. KanisH. Johansson Original Article 23 March 2021 Pages: 1973 - 1979
Alendronate use in older patients with reduced renal function: challenges and opportunities in clinical practice N. NaganatharW. -P. YauS. T. H. Chew Original Article 15 March 2021 Pages: 1981 - 1988
Geographical variation in surgical care and mortality following hip fracture in England: a cohort study using the National Hip Fracture Database (NHFD) A. ShahS. HawleyA. Judge Original Article 25 March 2021 Pages: 1989 - 1998
Early clinical effects, safety, and predictors of the effects of romosozumab treatment in osteoporosis patients: one-year study A. TominagaK. WadaY. Kato Original Article 26 March 2021 Pages: 1999 - 2009
Cost effectiveness of romosozumab versus teriparatide for severe postmenopausal osteoporosis in Japan H. HaginoK. TanakaB. Stollenwerk Original Article 27 March 2021 Pages: 2011 - 2021
Efficiently stratifying mid-term death risk in femoral fractures in the elderly: introducing the ASAgeCoGeCC Score C. TrevisanG. GallinariR. Klumpp Original Article 03 April 2021 Pages: 2023 - 2031
Higher latitude and lower solar radiation influence on hip fracture admissions in Chilean older population J. C. R. Ormeño IllanesI. Quevedo Langenegger Original Article 05 April 2021 Pages: 2033 - 2041
Height loss in postmenopausal women—do we need more for fracture risk assessment? Results from the GO Study W. PluskiewiczP. AdamczykB. Drozdzowska Original Article Open access 05 April 2021 Pages: 2043 - 2049
High prevalence of vertebral fractures in seizure patients with normal bone density receiving chronic anti-epileptic drugs P.M. DussaultD. McCarthyA.A. Lazzari Original Article 06 April 2021 Pages: 2051 - 2059
Health care utilization and excess costs after pelvic fractures among older people in Germany S. AndrichB. HaastertA. Icks Original Article Open access 10 April 2021 Pages: 2061 - 2072
Development and validation of the risk engine for an Australian Health Economics Model of Osteoporosis L. SiJ. A. EismanA. J. Palmer Original Article 15 April 2021 Pages: 2073 - 2081
Physical capability, physical activity, and their association with femoral bone mineral density in adults aged 40 years and older: The Tromsø study 2015–2016 A.V. HaugerK. HolvikB.H. Strand Original Article Open access 16 April 2021 Pages: 2083 - 2094
Risk factors for multi-joint disease in patients with glucocorticoid-induced osteonecrosis A. KrezJ. LaneE.M. Stein Original Article 20 April 2021 Pages: 2095 - 2103
Long-term evaluation of anabolic and anti-resorptive agents in adults with familial osteoporosis due to pro205ala variant of the col1a1 gene H.K. DattaJ. VilaS.P. Tuck Case Report 02 April 2021 Pages: 2105 - 2109
Asymptomatic elevated parathyroid hormone level due to immunoassay interference M.B. ZanchettaE. GiacoiaE. Fradinger Case Report 24 April 2021 Pages: 2111 - 2114
Subtrochanteric atypical femoral fracture induced solely by glucocorticoid without bisphosphonate treatment: a case report J.-T. KimY.-H. ChaC.H. Park Case Report 24 April 2021 Pages: 2115 - 2118
Progression of atypical femur stress fracture after discontinuation of bisphosphonate therapy K.D. GuB. EttingerJ.C. Lo Case Report 29 April 2021 Pages: 2119 - 2123
A cautionary case: osteoporotic femur fracture after robotic-assisted total knee arthroplasty H. E. SkibickiD. Y. PonzioF. R. Orozco Case Report 30 April 2021 Pages: 2125 - 2129
Denosumab is not associated with risk of malignancy: systematic review and meta-analysis of randomized controlled trials D. RosenbergT. AvniT. Diker-Cohen Letter to the Editor 12 August 2021 Pages: 2131 - 2131
Denosumab is not associated with risk of malignancy? More evidence is needed J. ZhaoH. QiuY. Lin Letter to the Editor 12 August 2021 Pages: 2133 - 2134
Letter to the Editor about the article “C-reactive protein and fracture risk: an updated systematic review and meta-analysis of cohort studies through the use of both frequentist and Bayesian approaches” R. C. Bajpai Letter to the Editor 12 August 2021 Pages: 2135 - 2136
Clarification of some issues using Bayesian methods and model selection in meta-analysis and reporting Q. WuH. MunB. Liu Letter to the Editor 12 August 2021 Pages: 2137 - 2138
Response to: “Zoledronate-induced acute anterior uveitis: a three-case report and brief review of literature” Priya SamaliaRachael Niederer Letter to the Editor 22 August 2021 Pages: 2139 - 2139
Correction to: The efficacy and safety of menatetrenone in the management of osteoporosis: a systematic review and meta-analysis of randomized controlled trials S. SuN. HeS. Zhai Correction 27 August 2021 Pages: 2141 - 2142
Correction to: A randomized, controlled trial of once-weekly teriparatide injection versus alendronate in patients at high risk of osteoporotic fracture: primary results of the Japanese osteoporosis intervention Trial-05 H. HaginoT. SugimotoS. Mori Publisher Correction 27 August 2021 Pages: 2143 - 2143
